Literature DB >> 7256325

Various intraperitoneal irrigation solutions in treating experimental fecal peritonitis.

K P Lally, R L Nichols.   

Abstract

To study the efficacy of several commonly used peritoneal lavage solutions in the treatment of experimental fecal peritonitis, lethal peritonitis was created in 100 rats by placing a gelatin capsule containing 0.1 ml of human stool and barium sulfate within the abdominal cavity. At reoperation up to eight hours after implantation, the rats had initial lavage with 30 ml/kg of sterile normal saline, followed by 15 ml/kg of one of four treatment regimens, all colored alike. These were 10% povidone-iodine (PVP-I), 1% PVP-I, 0.1% kanamycin, and sterile normal saline. A fifth group did not receive a second lavage. All survivors were sacrificed on the ninth day, at which time the study was unblinded. Twelve hours postoperatively there was a significantly greater mortality in the group irrigated with 10% PVP-I (83%) compared to all other groups (0-6%). At nine days, only the kanamycin group had survivors (29%); this was significantly better than any other group.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7256325     DOI: 10.1097/00007611-198107000-00006

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications.

Authors:  D L Dunn; R A Barke; D H Ahrenholz; E W Humphrey; R L Simmons
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

2.  Irrigation of peritoneal cavity with cold atmospheric plasma treated solution effectively reduces microbial load in rat acute peritonitis model.

Authors:  Mustafa Onur Oztan; Utku Kürşat Ercan; Ayşegül Aksoy Gokmen; Fatma Simsek; Gizem Dilara Ozdemir; Gökhan Koyluoglu
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

3.  Management of generalized faecal peritonitis--can we do better?

Authors:  J H Scholefield; A Wyman; K Rogers
Journal:  J R Soc Med       Date:  1991-11       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.